Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

NCT01289457 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

282

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: Clofarabine
DRUG: Idarubicin
DRUG: Cytarabine
DRUG: Fludarabine

Sponsor

M.D. Anderson Cancer Center